First human trial of AstraZeneca COVID-19 vaccine shows promise

  • 📰 YahooNews
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 59%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

AstraZeneca's experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain's University of Oxford, did not prompt any

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New YorkLONDON - AstraZeneca's experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.

"However, we need more research before we can confirm the vaccine effectively protects against SARS-CoV-2 infection, and for how long any protection lasts," he said. These include shots being developed by China's Sinovac Biotech, another from state-owned Chinese firm Sinopharm, and one from the U.S. biotech firm Moderna.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

They're rushing through a vaccine. No time to really study the side effects. Congress is trying to limit our ability to sue the manufacture if we're harmed. Think I'll pass.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 380. in LAW

Law Law Latest News, Law Law Headlines